-
Global Trends
European Authorities Clear Novel Autoimmune Therapy for Myasthenia Gravis
The European Commission has granted authorization for nipocalimab, an immunoglobulin G (IgG) receptor antagonist developed by Johnson & Johnson, for…
Read More » -
M&A
Eli Lilly Secures Experimental Cancer Therapy from Scorpion in Up-to-$2.5 Billion Deal
Eli Lilly announced its plan to acquire an experimental cancer therapy from Scorpion Therapeutics for a total consideration of up…
Read More » -
M&A
📰 Novartis Acquires Anthos Therapeutics for Up to $3.1 Billion to Boost Cardiovascular Pipeline
The Swiss pharmaceutical giant Novartis has reached an agreement to acquire Anthos Therapeutics, a biopharmaceutical firm majority-owned by the life…
Read More » -
M&A
Merck Finalizes $3.4 Billion Acquisition, Enhancing Rare Tumor Portfolio
Merck has successfully completed its previously announced $3.4 billion acquisition of SpringWorks Therapeutics, a biopharmaceutical company based in Stamford, Connecticut.…
Read More » -
M&A
Roche Commits $3.5 Billion to Bolster MASH Portfolio via 89bio Acquisition
Roche has announced its plan to acquire 89bio, a San Francisco-based biotechnology firm, in a strategic move valued at approximately…
Read More » -
M&A
Novo Nordisk Secures Key MASH Therapy in $5.2 Billion Strategic Deal
Global pharmaceutical giant Novo Nordisk has significantly strengthened its position in the treatment landscape for Metabolic Dysfunction-associated Steatohepatitis (MASH) with…
Read More » -
M&A
Merck Finalizes $10 Billion Acquisition of Verona Pharma with No Competing Bids
Merck successfully completed its $10 billion acquisition of Verona Pharma last month, a deal notable for the absence of a…
Read More » -
M&A
Johnson & Johnson Expands Neuroscience Portfolio with $14.6 Billion Acquisition
Global healthcare leader Johnson & Johnson (J&J) commenced the J.P. Morgan Healthcare Conference by announcing its intent to acquire Intra-Cellular…
Read More » -
M&A
Pharmaceutical Giant Finalizes Acquisition of Obesity Drug Developer
The global pharmaceutical corporation Pfizer Inc. has announced the successful conclusion of its acquisition of the clinical-stage biotechnology firm, Metsera,…
Read More » -
Global Trends
Vetter Managing Director to Retire Following Over Three Decades of Service
Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has announced the retirement of its Managing Director, Thomas Otto,…
Read More » -
Global Trends
New Study Suggests Shingles Vaccine May Slow Cognitive Decline
A new follow-up study, published in the journal Cell, adds evidence that the shingles vaccine, a two-dose shot recommended for…
Read More » -
Global Trends
Bristol Myers Bolsters Scale of Cobenfy Trial After Discovery of Site Irregularities
Bristol Myers Squibb (BMS) has announced an extension and increased enrollment for its late-stage clinical trial, “ADEPT-2,” of the drug…
Read More » -
Global Trends
Senior FDA Drug Regulator Steps Down Shortly After Appointment
The U.S. Food and Drug Administration (FDA) is once again searching for a leader for its Center for Drug Evaluation…
Read More » -
Global Trends
AI Chemistry Outfit Secures $95 Million to Accelerate Small Molecule Discovery and Production
Excelsior Sciences, an artificial intelligence (AI) chemistry firm, is gaining ground on its mission to hasten the discovery and production…
Read More » -
Global Trends
Campaign Raises Vision Health Awareness Targeting Aging Women
The Johnson & Johnson (J&J) corporation has teamed up with the acclaimed actress Naomi Watts in a communication campaign to…
Read More » -
Global Trends
New Leadership to Drive Strategic Growth in the Americas Region
Evonik, a global specialty chemicals company, has named executive Elias Lacerda President of the Americas region, effective February 1, 2026.…
Read More » -
Global Trends
Tech and Pharma Alliance Drives Patient-Centric Drug Development
The organization Citizen Health has entered into a multi-year strategic partnership with the pharmaceutical company UCB to expedite drug development…
Read More » -
Global Trends
Historic Zero Tariff Pharmaceutical Deal Agreed Between US and UK
The US government and the United Kingdom have announced an agreement in principle regarding pharmaceutical trade, under which UK pharmaceutical…
Read More » -
Global Trends
-
Global Trends
US-UK Trade Deal: Drug Tariff Exemption Secured in Exchange for Healthcare Spending Reforms
Source: https://www.fiercepharma.com/pharma/trump-administration-locks-trade-deal-setting-uk-drug-tariffs-zero
Read More »
